Registration Options

Activity Dates: 05/10/2021 - 04/21/2024

Members can access this product for only $35. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Scientific leaders, including the Alzheimer's Association and representatives from more than 25 countries, are working together with technical guidance from the World Health Organization (WHO) to track the long-term impact of SARS-CoV-2 (also known as novel coronavirus, COVID-19) on the brain. The ongoing pandemic of SARS-CoV-2 has focused global health care resources on treating affected individuals and preventing the further spread of the infection. Although little is known about the long-term consequences of SARS-CoV-2 infection, there are several research studies to suggest that COVID-19 is associated with neurological complications. The downstream impact of COVID-19 on the brain is not well understood. There are many unanswered questions regarding the effects of SARS-CoV-2 on the cerebrovascular system (e.g., blood-brain barrier integrity), the brain's immune response and more.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Provide an overview of the neurological complications of SARS-CoV-2 infection, especially clinical presentation related to the central nervous system.
  2. Discuss the biological characteristics of SARS-CoV-2 that cause direct or indirect brain injury and reason for common manifestation of hyposmia/anosmia, dysgeusia, headache, fatigue and altered mental status.
  3. Evaluate the evidence for and against a higher risk of stroke and cerebrovascular disease and subsequent neurodegeneration in SARS-CoV-2 infected individuals.
  4. Summarize ongoing efforts and findings to understand possible impact of genetic, geographic, race, ethnic and other factors in determining immediate and long-term neurological sequelae.

Continuing Education Credit and Disclosures

Activity Dates: 05/10/2021 - 04/21/2024
ACPE Contact Hours: 1
ACPE Number: 0284-0000-21-010-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.